The Jefferson School of Pharmacy is dedicated to collaborative research initiatives that focus on disease etiology, development of novel therapies, drug outcomes and their economic impact, and enhanced patient care. As part of our strategic plan, we are building our expertise and infrastructure to foster research collaboration with industry and government partners, and with the world-renowned researchers at Jefferson.
- Dr. Laura Pizzi is the first faculty member at the Jefferson School of Pharmacy to focus on interpreting and applying the tools of economic evaluation to the challenges of today’s healthcare landscape.
- Dr. Takemi Tanaka's research could lead to a better understanding of cancer etiology and development of novel targeted therapy in conjunction with nanotechnology
- Dr. Omar Tliba's research findings inform the design of new therapeutic agents or alternatives to treat steroid resistance.